Primary Site >> Colorectal Cancer
Gene >> CXCL13
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver. PMID: 17018614 |
Ref: ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. PMID: 22213796 Ref: NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-kappaB signaling. PMID: 22503542 |
Ref: Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer. PMID: 23868006 Ref: Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. PMID: 24138885 |
Ref: Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer. PMID: 25010623 |
Ref: CXCL13-CXCR5 axis promotes the growth and invasion of colon cancer cells via PI3K/AKT pathway. PMID: 25476740 Ref: Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial. PMID: 25970543 |
Ref: Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3(+) regulatory T cells in murine colon cancer. PMID: 28405523 Ref: Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer. PMID: 28974887 |
Ref: Gut microbiota modulate T cell trafficking into human colorectal cancer. PMID: 29437871 |